Creates and funds a biospecimen core resource (BCR) under the cancer moonshot biobank (CMB) program with the national cancer institute (NCI) biorepositories and biospecimen research branch (bbrb).
Active Awarded Last action
- Contract number
- 75N91022F00001
- Awardee
-
Van Andel Research Institute UEI QLRCUJ8JTN53
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,912,119
Award facts
- Contract value 100% obligated
- $7,912,119.00 Current and potential, with all options
- Completion date 86% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Wyoming, MI 49503, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $7,912,119 |
About this award
The Van Andel Research Institute, doing business as VAI, has been awarded a $7.9 million cost-no-fee Delivery Order contract by the Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) to create and fund a Biospecimen Core Resource (BCR) under the Cancer Moonshot Biobank (CMB) program. VAI will serve as the prime contractor and BCR to perform biospecimen collection and storage services for the NCI. A subcontract valued at an undisclosed amount was also awarded to Health Research, Inc. Roswell Park Division, doing business as Health Research-Roswell Park Cancer Institute Division, to provide hematopathology and surgical case review services of 75-100 Acute Myeloid Leukemia and Multiple Myeloma cases annually as well as 20 solid tumor cases per year.
Quick answers
Who was awarded contract 75N91022F00001?
75N91022F00001 was awarded to Van Andel Research Institute by National Cancer Institute (National Institutes of Health) on June 28, 2022.
How much is contract 75N91022F00001 worth?
The government has obligated $7,912,119 on 75N91022F00001.
Is contract 75N91022F00001 an order under another contract?
Yes. 75N91022F00001 is a delivery order under 75N91022D00008, an indefinite delivery contract.
Was contract 75N91022F00001 competed?
The extent of competition for 75N91022F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award